| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa
|
Mwita, Julius Chacha
|
|
|
57 |
4 |
p. 613-621
|
artikel
|
| 2 |
Antithrombotic strategies for preventing graft failure in coronary artery bypass graft
|
Mauro, Maria Sara
|
|
|
57 |
4 |
p. 547-557
|
artikel
|
| 3 |
A systematic review of therapeutic enoxaparin dosing in obesity
|
Chilbert, Maya R.
|
|
|
57 |
4 |
p. 587-597
|
artikel
|
| 4 |
A ten-year comparison of treatment and outcomes of cancer-associated thrombosis to non-cancer venous thromboembolism: from traditional anticoagulants to direct oral anticoagulants
|
Wee, Benjamin
|
|
|
57 |
4 |
p. 658-667
|
artikel
|
| 5 |
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database
|
Truong, Bang
|
|
|
57 |
4 |
p. 638-649
|
artikel
|
| 6 |
COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment
|
Liu, Li-Hua
|
|
|
57 |
4 |
p. 730-738
|
artikel
|
| 7 |
Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory
|
Gurbel, Paul A.
|
|
|
57 |
4 |
p. 566-575
|
artikel
|
| 8 |
Discrimination of the acute pulmonary embolism subtypes based on the novel MAPH score
|
Akhan, Onur
|
|
|
57 |
4 |
p. 683-690
|
artikel
|
| 9 |
Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
|
Buka, Richard J
|
|
|
57 |
4 |
p. 739-741
|
artikel
|
| 10 |
Impact of hemodialysis on efficacies of the antiplatelet agents in coronary artery disease patients complicated with end-stage renal disease
|
Ye, Zekang
|
|
|
57 |
4 |
p. 558-565
|
artikel
|
| 11 |
Impact of rise and fall phases of shear on platelet activation and aggregation using microfluidics
|
Gao, Xuemei
|
|
|
57 |
4 |
p. 576-586
|
artikel
|
| 12 |
Is a minimum duration of 5 days of unfractionated heparin infusion necessary before transition to oral anticoagulation in cerebral venous thrombosis? a retrospective chart review
|
Carrion, Ariel N.
|
|
|
57 |
4 |
p. 691-698
|
artikel
|
| 13 |
Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome
|
Wu, Yee-Jen
|
|
|
57 |
4 |
p. 537-546
|
artikel
|
| 14 |
Management of direct oral anticoagulant drug interactions in hospitalized patients
|
Al Zaria, Mohsen H.
|
|
|
57 |
4 |
p. 598-602
|
artikel
|
| 15 |
Management of DOAC-related bleeding in cancer patients: a single center-case series
|
Lee, Sophia
|
|
|
57 |
4 |
p. 677-682
|
artikel
|
| 16 |
One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke
|
Murakami, Yasutaka
|
|
|
57 |
4 |
p. 622-629
|
artikel
|
| 17 |
Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry
|
Cohen, Omri
|
|
|
57 |
4 |
p. 710-720
|
artikel
|
| 18 |
Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity
|
Okazaki, Erica
|
|
|
57 |
4 |
p. 721-729
|
artikel
|
| 19 |
Prediction of mortality in acute pulmonary embolism in cancer-associated thrombosis (MAUPE-C): derivation and validation of a multivariable model
|
Aramberri, Mario
|
|
|
57 |
4 |
p. 668-676
|
artikel
|
| 20 |
Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity
|
Sperry, Jeffrey D.
|
|
|
57 |
4 |
p. 603-612
|
artikel
|
| 21 |
Superficial vein thrombosis and its relationship with malignancies: a prospective observational study
|
Díez-Vidal, Alejandro
|
|
|
57 |
4 |
p. 650-657
|
artikel
|
| 22 |
The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review
|
Al-Tourah, L.
|
|
|
57 |
4 |
p. 630-637
|
artikel
|
| 23 |
Therapeutic implication of MicroRNA-320a antagonist in attenuating blood clots formed during venous thrombosis
|
Srivastava, Swati
|
|
|
57 |
4 |
p. 699-709
|
artikel
|
Tijdschrift beschrijving